BRAF inhibitors and their immunological effects in malignant melanoma. (2022)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/1744666x.2022.2044796
PubMed Identifier: 35195495
Publication URI: http://europepmc.org/abstract/MED/35195495
Type: Journal Article/Review
Volume: 18
Parent Publication: Expert review of clinical immunology
Issue: 4
ISSN: 1744-666X